Dana Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Dana Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,529	Closed	-$621K	–	421
2022 Q3	$621K	Hold	2,529	–	–	0.04%	279
2022 Q2	$626K	Buy	+2,529	New	+$682K	0.03%	284

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dana Investment Advisors's ABMD Position: Q4 2022 in Review

Dana Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,529 shares — an estimated $621K sold.

Dana Investment Advisors first reported a position in ABMD in Q2 2022 and held it in 2 quarters. The position peaked at $626K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Dana Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Dana Investment Advisors sold 2,529 Abiomed Inc shares in Q4 2022, an estimated $621K.
Dana Investment Advisors first reported a position in Abiomed Inc in Q2 2022 and held it in 2 quarters.
Dana Investment Advisors's Abiomed Inc position peaked at $626K in Q2 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Dana Investment Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.